Lv31
290 积分 2024-12-24 加入
Exercise Pathophysiology in Interstitial Lung Disease
3天前
已完结
Pulmonary Hypertension in Interstitial Lung Disease
3天前
已完结
Pathogenesis of chronic bronchitis
11天前
已关闭
Chronic bronchitis – new clinical recommendations (main provisions): A review on behalf of the working group for the development and revision of clinical guidelines for chronic bronchitis
11天前
已完结
Advances in the development of antimicrobial peptides and proteins for inhaled therapy
1个月前
已完结
[Research prospect of cyclic nucleotide phosphodiesterase 3/4 inhibitors in chronic obstructive pulmonary disease]
4个月前
已完结
Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment
5个月前
已完结
Encapsulation of beraprost sodium in nanoparticles: Analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension
5个月前
已完结
Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery
5个月前
已完结
SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension
5个月前
已完结
皖公网安备34019202002308
